Nira Ben-Jonathan

Nira Ben-Jonathan

Professor

Vontz Center

2122

COM Cancer Biology - 0521

Vontz Center for Molecular Studies
3125 Eden Avenue
Cincinnati, Ohio 45267

Professional Summary

Nira Ben-Jonathan, Professor of Cancer and Cell Biology, received her undergraduate degree from Tel Aviv University in Israel and a Doctor of Philosophy Degree from the University of Illinois. She was a postdoctoral fellow at the University of Texas and a faculty member in the Department of Physiology at the Indiana University Medical School; she joined the University of Cincinnati as Professor in 1992. The Ben-Jonathan laboratory is involved in three major lines of investigation. The first is to examine both genomic and non genomic effects of estrogens and xenoestrogens on gene expression and cell proliferation in pituitary and breast cancer cells. The second, to investigate the role of prolactin, produced in human breast tissue, in the promotion of breast cancer via its actions as a mitogen and an anti-apoptotic agent. The third is to use animal models, cell lines and human tissues to determine the regulation of prolactin gene expression in adipose tissue and analyze its metabolic/endocrine functions as pertains to the control of lipolysis and adipokine production and release.

Education

Bachelor's Degree, Tel Aviv University 1967 (Biology)

Master's Degree, University of Illinois 1969 (Physiology)

Doctoral Degree, University of Illinois 1972 (Physiology)

Positions and Work Experience

1975 - Assistant Professor, Dept. of Physiology, Indiana University Medical School, Indianapolis, Indiana

1979 - Associate Professor, Dept. of Physiology, Indiana University Medical School, Indianapolis, Indiana

1983 - Full Professor, Dept. of Physiology, Indiana University Medical School, Indianapolis, Indiana

1991 -1998 Visiting Lecturer (1 week/year) in Neuroendocrinology, Free University Brussels, Belgium.,

1992 -To Present Professor, Department of Cancer and Cell Biology, University of Cincinnati Medical School, Cincinnati, Ohio

2004 - Sabbatical leave, Dept of Biological Regulation, The Weizmann Institute, Rehovot, Israel

2009 -To Present Professor, Department of Internal Medicine, University of Cincinnati Medical School, Cincinnati, Ohio

Research and Practice Interests

Research Interests: Control of prolactin, LH and GH synthesis and secretion; posterior pituitary hormones; catecholamines in the hypothalamo-pituitary-ovarian axis; fetal/neonatal development; axoplasmic transport; dopamine receptors; tyrosine hydroxylase; serotonergic systems; electrophysiology of pituitary cells; purification of neuropeptides; immunocytochemistry and in situ hybridization; cell proliferation and differentiation; regulation of prolactin gene expression; role of prolactin in breast and prostate cancer; environmental estrogens; bisphenol A; immediate early genes; distribution and regulation of estrogen receptors; transgenic mice; human prolactinomas; heparin-binding growth factors; angiogenesis in the pituitary and breast cancer; liposarcoma; prolactin in adipose tissue; prolactin in obesity; non-genomic actions of estrogens and antiestrogens; metabolic actions of prolactin; lipolysis, adipokine release, chemotherapeutic agents; insulin; dopamine receptors in adipose tissue and breast cancer; drug discovery in breast cancer; placental lactogen; effects of antipsychotics on adipocyte functions; dopamine receptors in head and neck cancer.

Research Support

Grant: #NIH RO1-CA096613-06 09-01-2009 -08-31-2014 Prolactin as a Growth Factor in Breast Cancer Role:PI Active

Grant: #NIH R21-ES16803-01 08-01-2008 -07-30-2010 Exposure to Bisphenol A: Suppression of Adiponectin Release by Human Adipocytes Role:PI

01-01-2010 -12-31-2011 Elsa U Pardee Foundation Placental Lactogen as a Serological Marker in Breast Cancer Role:PI Active

Grant: #NIH R01 ES012212 05-01-2003 -03-31-2007 Xenoestrogens: Genomic and Non-genomic Mechanisms Role:PI Completed

Grant: #BCRT 87406 05-01-2006 -04-30-2009 Komen Foundation In vitro and in vivo Models for Chemoresistance Role:PI Completed

Grant: #DOD BC050725 03-01-2006 -02-28-2010 Antagonism of Taxol Cytotoxicity by Prolactin: Implications for Patient Resistance to Chemotherapy Role:PI Completed

Grant: #BCTR87406 Investigators:Ben-Jonathan, Nira 05-01-2006 -04-30-2009 Susan G. Komen Breast Cancer Foundation In Vitro and In Vivo Models for Chemoresistance Role:PI $250,000.00 Active Level:Private Non-Profit

Grant: #W81XWH-06-1-0359 Investigators:Ben-Jonathan, Nira 02-15-2006 -02-14-2010 Department of the Army Medical Research and Materiel Command Antagonism of Taxol Cytotoxicity by Prolactin: implications for Patient Resistance to Chemotherapy Role:PI $460,500.00 Closed Level:Federal

Grant: #SRS 001935 Investigators:Ben-Jonathan, Nira; Hugo, Eric 03-03-2007 -03-02-2008 Novo Nordisk A/S Novo Nordisk Role:PI $117,000.00 Closed Level:Foreign Industry

Grant: #R01 CA096613 Investigators:Ben-Jonathan, Nira 02-15-2004 -01-31-2010 National Cancer Institute Prolactin as a Growth Factor in Breast Cancer Role:PI $1,458,574.24 Closed Level:Federal

Grant: #R01-ES-012212 Investigators:Ben-Jonathan, Nira 05-02-2003 -03-31-2008 National Institute of Environmental Health Sciences Xenoestrogens: Genomic and Non-genomic Mechanisms Role:PI $1,142,369.00 Closed Level:Federal

Investigators:Ben-Jonathan, Nira 05-01-2003 -04-30-2005 Susan G. Komen Breast Cancer Foundation Regulation of Prolactin Production by Normal & Malignant Breast Tissues Role:PI $30,000.00 Closed Level:Private Non-Profit

Grant: #1-R55-CA-80920-01-A1-S0-E0 Investigators:Ben-Jonathan, Nira 04-01-2000 -03-31-2005 National Cancer Institute Angiostatic Function of Human 16K Prolactin Role:PI $100,000.00 Closed Level:Federal

Grant: #PARDEE-03-02-A0-S0-E0 Investigators:Ben-Jonathan, Nira 10-01-1999 -09-30-2002 Elsa U. Pardee Foundation Suppression of Metastases by Anti-Angiogenic Agents: Development of Novel In Vivo Delivery Systems Role:PI $171,566.00 Closed Level:Private Non-Profit

Investigators:Ben-Jonathan, Nira 08-15-2000 -07-31-2003 National Science Foundation Pituitary VEGF: Cellular Distribution, Regulation, and Function Role:PI $300,000.00 Closed Level:Federal

Grant: #5-R21-DK-060904-02-A0-S0-E0 Investigators:Ben-Jonathan, Nira 09-30-2001 -08-31-2004 National Inst of Diabetes and Digestive and Kidney Disease Prolactin and Estrogens as Mitogens in Prostate Cancer Role:PI $306,000.00 Closed Level:Federal

Grant: #5-R01-NS-13243-18-A0-S0-E0 Investigators:Ben-Jonathan, Nira 09-01-1995 -05-31-2000 National Institute of Neurological Disorders and Stroke Paracrine Regulation of Pituitary Lactotrophs Role:PI $635,867.00 Closed Level:Federal

Grant: #6FY98-0159-02-A0-S0-E0 Investigators:Ben-Jonathan, Nira 06-01-1998 -05-31-2000 March of Dimes Estrogenic and Genotoxic Effects of Bisphenol A Role:PI $120,000.00 Closed Level:Private Non-Profit

Grant: #5-R03-ES-10154-02-A0-S0-E0 Investigators:Ben-Jonathan, Nira 09-30-1999 -09-29-2002 National Institute of Environmental Health Sciences Xenoestrogens and the Developing Neuroendocrine Axis Role:PI $153,000.00 Closed Level:Federal

Grant: #5-R01-ES-09555-04-A0-S0-E0 Investigators:Ben-Jonathan, Nira 03-01-2000 -02-28-2005 National Institute of Environmental Health Sciences Neonatal Effects and Metabolism of Xenoestrogens Role:PI $928,763.00 Closed Level:Federal

Grant: #K99 ES016817 Investigators:Belcher, Scott; Ben-Jonathan, Nira; Ho, Shuk Mei; Levin, Linda; Revelo-Penafiel, Monica; Tam, Neville Ngai Chung; Tang, Wan Yee 09-02-2008 -08-31-2010 National Institute of Environmental Health Sciences Estrogens/Xenoestrogens and Epigenetic Regulation of Gene Expression Role:Collaborator $180,000.00 Closed Level:Federal

Grant: #R21 ES016803 Investigators:Ben-Jonathan, Nira 09-01-2008 -08-31-2011 National Institute of Environmental Health Sciences Exposure to Bisphenol A; Inhibition of Adiponectin Release by Human Adipocytes Role:PI $429,000.00 Closed Level:Federal

Grant: #R01 CA096613 Investigators:Ben-Jonathan, Nira 09-01-2009 -07-31-2014 National Cancer Institute Prolactin as a Growth Factor in Breast Cancer Role:PI $990,760.00 Active Level:Federal

Grant: #3 R21 ES016803-02S1 Investigators:Ben-Jonathan, Nira 09-17-2009 -08-31-2010 National Institute of Environmental Health Sciences Exposure to Bisphenol A: Suppression of Adiponectin Release by Human Adipocytes Role:PI $113,868.00 Closed Level:Federal

Grant: #CK 3138 Investigators:Ben-Jonathan, Nira 01-01-2010 -12-31-2010 Elsa U. Pardee Foundation Placental Lactogen as a Serological Marker for Breast Cancer Role:PI $125,000.00 Closed Level:Private Non-Profit

Grant: #U01 ES019480 Investigators:Belcher, Scott; Ben-Jonathan, Nira; Ho, Shuk Mei; Levin, Linda; Medvedovic, Mario; Miller, Marian; Stambrook, Peter; Tso, Patrick P.W. 09-22-2010 -05-31-2015 National Institute of Environmental Health Sciences Susceptible Window of High Fat Diet/Bisphenol A Programming of Breast Cancer Risk Role:Collaborator $1,790,100.00 Active Level:Federal

Grant: #R13ES020088 Investigators:Ben-Jonathan, Nira 02-15-2011 -01-31-2012 National Institute of Environmental Health Sciences Satellite Symposium on Obesity and Endocrine Disruptors Role:PI $8,000.00 Closed Level:Federal

Grant: #SRS 007454 Investigators:Ben-Jonathan, Nira 05-01-2011 -06-30-2011 Passport Foundation Satellite Symposium on Obesity and Endocrine Disruptors Role:PI $4,000.00 Closed Level:Private Non-Profit

Grant: #U01 ES020909 Investigators:Ben-Jonathan, Nira; Hugo, Eric 09-19-2011 -05-31-2015 National Institute of Environmental Health Sciences Bisphenol A and the Metabolic Syndrome: Focus on Adipose Tissue Functions Role:PI $662,307.00 Active Level:Federal

Grant: #Contract W81XWH-12-1-0611 Req W91ZSQ2105N644 Investigators:Ben-Jonathan, Nira; Richtand, Neil; Sakai, Randall 09-30-2012 -09-29-2015 Department of the Army Medical Research Acquisition Activity Metabolic Signature of Antipsychotics Used in the Treatment of Autism Role:PI $588,750.00 Active Level:Federal

Grant: #W81XWH-13-1-0295 Investigators:Ben-Jonathan, Nira 09-01-2013 -08-31-2016 Department of the Army Medical Research Acquisition Activity BC122992-Therapeutic and Imaging Applications of Dopamine Receptor Agonists in Breast Cancer Role:PI $593,646.00 Awarded Level:Federal

Grant: #BCG2017 Investigators:Ben-Jonathan, Nira 09-01-2017 -09-01-2018 Brandon C. Gromada Head and Neck Cancer Foundation Novel treatments for head and neck cancer using FDA-approved drugs Role:PI $20,000.00 Active Level:Private Non-Profit

Publications

Peer Reviewed Publications

Cifuentes, Mariana; Fuentes, Cecilia; Mattar, Pamela; Tobar, Nicolas; Hugo, Eric; Ben-Jonathan, Nira; Rojas, Cecilia; Martínez, Jorge (2010. )Obesity-associated proinflammatory cytokines increase calcium sensing receptor (CaSR) protein expression in primary human adipocytes and LS14 human adipose cell line.Archives of biochemistry and biophysics, ,500 (2 ),151-6

LaPensee, Elizabeth W; LaPensee, Christopher R; Fox, Sejal; Schwemberger, Sandy; Afton, Scott; Ben-Jonathan, Nira (2010. )Bisphenol A and estradiol are equipotent in antagonizing cisplatin-induced cytotoxicity in breast cancer cells.Cancer letters, ,290 (2 ),167-73

Kansra, Sanjay; Chen, Shenglin; Bangaru, Madhavi Latha Yadav; Sneade, Leighton; Dunckley, Joseph A; Ben-Jonathan, Nira (2010. )Selective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate lactotroph proliferation.PloS one, ,5 (4 ),e10060

LaPensee, Elizabeth W; Ben-Jonathan, Nira (2010. )Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy.Endocrine-related cancer, ,17 (2 ),R91-107

Chen, Shenglin; Bangaru, Madhavi Latha Yadav; Sneade, Leighton; Dunckley, Joseph A; Ben-Jonathan, Nira; Kansra, Sanjay (2009. )Epidermal growth factor receptor cross-talks with ligand-occupied estrogen receptor-alpha to modulate both lactotroph proliferation and prolactin gene expression.American journal of physiology. Endocrinology and metabolism, ,297 (2 ),E331-9

LaPensee, Elizabeth W; Schwemberger, Sandy J; LaPensee, Christopher R; Bahassi, El Mustapha; Afton, Scott E; Ben-Jonathan, Nira (2009. )Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase.Carcinogenesis, ,30 (8 ),1298-304

Ben-Jonathan, Nira; Hugo, Eric R; Brandebourg, Terry D (2009. )Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome.Molecular and cellular endocrinology, ,304 (1-2 ),49-54

Ben-Jonathan, Nira; Chen, Shenglin; Dunckley, Joseph A; LaPensee, Christopher; Kansra, Sanjay (2009. )Estrogen receptor-alpha mediates the epidermal growth factor-stimulated prolactin expression and release in lactotrophs.Endocrinology, ,150 (2 ),795-802

Lapensee, Elizabeth W; Tuttle, Traci R; Fox, Sejal R; Ben-Jonathan, Nira (2009. )Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells.Environmental health perspectives, ,117 (2 ),175-80

Hugo, Eric R; Brandebourg, Terry D; Woo, Jessica G; Loftus, Jean; Alexander, J Wesley; Ben-Jonathan, Nira (2008. )Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes.Environmental health perspectives, ,116 (12 ),1642-7

LaPensee, Christopher R; Hugo, Eric R; Ben-Jonathan, Nira (2008. )Insulin stimulates interleukin-6 expression and release in LS14 human adipocytes through multiple signaling pathways.Endocrinology, ,149 (11 ),5415-22

Hugo, Eric R; Borcherding, Dana C; Gersin, Keith S; Loftus, Jean; Ben-Jonathan, Nira (2008. )Prolactin release by adipose explants, primary adipocytes, and LS14 adipocytes.The Journal of clinical endocrinology and metabolism, ,93 (10 ),4006-12

Ben-Jonathan, Nira; LaPensee, Christopher R; LaPensee, Elizabeth W (2008. )What can we learn from rodents about prolactin in humans?.Endocrine reviews, ,29 (1 ),1-41

Brandebourg, Terry D; Bown, Jenna L; Ben-Jonathan, Nira (2007. )Prolactin upregulates its receptors and inhibits lipolysis and leptin release in male rat adipose tissue.Biochemical and biophysical research communications, ,357 (2 ),408-13

LaPensee, Elizabeth W; Reddy, Shamantha P; Hugo, Eric R; Schwemberger, Sandy J; Ben-Jonathan, Nira (2007. )LS14 cells: a model for chemoresistance in liposarcoma. Cancer biology & therapy, ,6 (4 ),519-24

LaPensee, Christopher R; Horseman, Nelson D; Tso, Patrick; Brandebourg, Terry D; Hugo, Eric R; Ben-Jonathan, Nira (2006. )The prolactin-deficient mouse has an unaltered metabolic phenotype.Endocrinology, ,147 (10 ),4638-45

Hnasko, Robert; Frank, Philippe G; Ben-Jonathan, Nira; Lisanti, Michael P (2006. )PV-1 is negatively regulated by VEGF in the lung of caveolin-1, but not caveolin-2, null mice. Cell cycle (Georgetown, Tex.), ,5 (17 ),2012-20

McFarland-Mancini, Molly; Hugo, Eric; Loftus, Jean; Ben-Jonathan, Nira (2006. )Induction of prolactin expression and release in human preadipocytes by cAMP activating ligands.Biochemical and biophysical research communications, ,344 (1 ),9-16

Ben-Jonathan, Nira; Hugo, Eric R; Brandebourg, Terry D; LaPensee, Christopher R (2006. )Focus on prolactin as a metabolic hormone.Trends in endocrinology and metabolism: TEM, ,17 (3 ),110-6

Hugo, Eric R; Brandebourg, Terry D; Comstock, Clay E S; Gersin, Keith S; Sussman, Jeffrey J; Ben-Jonathan, Nira (2006. )LS14: a novel human adipocyte cell line that produces prolactin.Endocrinology, ,147 (1 ),306-13

Ben-Jonathan, Nira (2005. )Dopamine and transforming growth factor-beta1: an odd couple in growth inhibition of the lactotrophs.Endocrinology, ,146 (10 ),4177-8

Kansra, Sanjay; Yamagata, Sayaka; Sneade, Leighton; Foster, Lauren; Ben-Jonathan, Nira (2005. )Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.Molecular and cellular endocrinology, ,239 (1-2 ),27-36

Hnasko, Robert; Ben-Jonathan, Nira (2005. )Developmental regulation of PV-1 in rat lung: association with the nuclear envelope and limited colocalization with Cav-1.American journal of physiology. Lung cellular and molecular physiology, ,288 (2 ),L275-84

Liby, Karen; Neltner, Bonnie; Mohamet, Lisa; Menchen, Lindsey; Ben-Jonathan, Nira (2003. )Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth. Breast cancer research and treatment, ,79 (2 ),241-52

Hnasko, Robert; Ben-Jonathan, Nira Prolactin regulation by heparin-binding growth factors expressed in mouse pituitary cell lines.Endocrine, ,20 (1-2 ),35-44

Zinger, Michael; McFarland, Molly; Ben-Jonathan, Nira (2003. )Prolactin expression and secretion by human breast glandular and adipose tissue explants. The Journal of clinical endocrinology and metabolism, ,88 (2 ),689-96

Liby, Karen; Neltner, Bonnie; Mohamet, Lisa; Burd, Craig; Ben-Jonathan, Nira Endostatin expression by MDA-MB-435 breast cancer cells effectively inhibits tumor growth. Cancer biology & therapy, ,2 (1 ),48-52

Ben-Jonathan, Nira; Liby, Karen; McFarland, Molly; Zinger, Michael (2002. )Prolactin as an autocrine/paracrine growth factor in human cancer. Trends in endocrinology and metabolism: TEM, ,13 (6 ),245-50

Marano, Robert J; Ben-Jonathan, Nira (2014. )Minireview: extrapituitary prolactin: an update on the distribution, regulation, and functions.Molecular endocrinology (Baltimore, Md.), ,28 (5 ),622-33

Tuttle, TR; Hugo, ER; Tong, WS; Ben-Jonathan, N (2014. )Placental lactogen is expressed but is not translated into protein in breast cancer.PloS One, ,9 (1 ),e87325

Villarroel, Pia; Reyes, Marcela; Fuentes, Cecilia; Segovia, María Pia; Tobar, Nicolás; Villalobos, Elisa; Martínez, Jorge; Hugo, Eric; Ben-Jonathan, Nira; Cifuentes, Mariana (2013. )Adipogenic effect of calcium sensing receptor activation.Molecular and cellular biochemistry, ,384 (1-2 ),139-45

Lo, Yuan-Hung; Ho, Po-Chun; Chen, Min-Shan; Hugo, Eric; Ben-Jonathan, Nira; Wang, Shao-Chun (2013. )Phosphorylation at tyrosine 114 of Proliferating Cell Nuclear Antigen (PCNA) is required for adipogenesis in response to high fat diet.Biochemical and biophysical research communications, ,430 (1 ),43-8

Cifuentes, Mariana; Fuentes, Cecilia; Tobar, Nicolas; Acevedo, Ingrid; Villalobos, Elisa; Hugo, Eric; Ben-Jonathan, Nira; Reyes, Marcela (2012. )Calcium sensing receptor activation elevates proinflammatory factor expression in human adipose cells and adipose tissue.Molecular and cellular endocrinology, ,361 (1-2 ),24-30

Idelman, Gila; Jacobson, Eric M; Tuttle, Traci R; Ben-Jonathan, Nira (2011. )Lactogens and estrogens in breast cancer chemoresistance.Expert review of endocrinology & metabolism, ,6 (3 ),411-422

Jacobson, Eric M; Hugo, Eric R; Borcherding, Dana C; Ben-Jonathan, Nira (2011. )Prolactin in breast and prostate cancer: molecular and genetic perspectives. Discovery medicine, ,11 (59 ),315-24

Borcherding, Dana C; Hugo, Eric R; Idelman, Gila; De Silva, Anuradha; Richtand, Nathan W; Loftus, Jean; Ben-Jonathan, Nira (2011. )Dopamine receptors in human adipocytes: expression and functions.PloS one, ,6 (9 ),e25537

Jacobson, Eric M; Hugo, Eric R; Tuttle, Traci R; Papoian, Ruben; Ben-Jonathan, Nira (2010. )Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.Trends in endocrinology and metabolism: TEM, ,21 (11 ),691-8

Ben-Jonathan, Nira; Hugo, Eric (2015. )Prolactin (PRL) in adipose tissue: regulation and functions.Advances in experimental medicine and biology, ,846 ,1-35

Garrison, Jason B; Ge, Chunmin; Che, Lixiao; Pullum, Derek A; Peng, Guang; Khan, Sohaib; Ben-Jonathan, Nira; Wang, Jiang; Du, Chunying (2015. )Knockdown of the Inhibitor of Apoptosis BRUCE Sensitizes Resistant Breast Cancer Cells to Chemotherapeutic Agents.Journal of cancer science & therapy, ,7 (4 ),121-126

Tuttle, Traci R; Mierzwa, Michelle L; Wells, Susanne I; Fox, Sejal R; Ben-Jonathan, Nira (2016. )The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma.Cancer letters, ,370 (2 ),279-85

Tuttle, Traci R; Takiar, Vinita; Kumar, Bhavna; Kumar, Pawan; Ben-Jonathan, Nira (2017. )Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells.Cancer letters, ,389 ,33-40

Ben-Jonathan N, Hugo ER (2016. )Bisphenols Come in Different Flavors: Is "S" Better Than "A"?.Endocrinology, ,157 ,1321-1323

Borcherding DC, Tong W, Hugo ER, Barnard DF, Fox S, LaSance K, Shaughnessy E, Ben-Jonathan N (2016. )Expression and therapeutic applications of dopamine receptor-1 (D1R) in breast cancer.Oncogene, ,35 ,3103-3113

Ben-Jonathan, Nira; Hugo, Eric R (2016. )Bisphenols Come in Different Flavors: Is "S" Better Than "A"?.Endocrinology, ,157 (4 ),1321-3

Honors and Awards

1978 -1982 Hormonal Functions of Catecholamines Research Career Development Award, NIH

1978 -1982 Hormonal Functions of Catecholamines Research Career Development Award, NIH

1985 Fellow American Association for the Advancement of Science

2003 University of Cincinnati Rieveschl Award for Outstanding Scientific Research

Keywords

Anatomy(MeSH A),Organisms(MeSH B),Diseases(MeSH C),Chemicals and Drugs(MeSH D),Biological Sciences(MeSH G),Endocrine System(MeSH A06),Nervous System(MeSH A08),Tissues(MeSH A10),Cells(MeSH A11),Fluids and Secretions(MeSH A12),Vertebrates(MeSH B02),Neoplasms(MeSH C04),Endocrine Diseases(MeSH C19),Disorders of Environmental Origin(MeSH C21),Environmental Pollutants, Noxae, and Pesticides(MeSH D05),Hormones, Hormone Substitutes, and Hormone Antagonists(MeSH D06),Reproductive Control Agents(MeSH D07),Growth Substances, Pigments, and Vitamins(MeSH D11),Amino Acids, Peptides, and Proteins(MeSH D12),Neurotransmitters and Neurotransmitter Agents(MeSH D14),Central Nervous System Agents(MeSH D15),Environment and Public Health(MeSH G03),Biochemical Phenomena, Metabolism, and Nutrition(MeSH G06),Physiological Processes(MeSH G07),Reproductive and Urinary Physiology(MeSH G08)

Professional Affiliation

1981 -2008: Editorial Boards Endocrinology; Neuroendocrinology; Biology of Reproduction; Pituitary.

1983: Organizer International Symposium: "Catecholamines as Hormone Regulators", Indianapolis, IN

1984 -1988: Member and Chairman NIH, Endocrinology Study Section,

1990: Chairman NIH, Programs of Excellence in Endocrine Research Study Section,

1991: Member, Program Committee Society for the Study of Reproduction.,

1992: Chairman Gordon Research Conference on Prolactin.,

1993 -1996: Ad hoc member NIH, Endocrinology & Reproduction; Endocrinology Fellowship Study Sections. ,

1996 -2010: Member US Army Breast Cancer Research Program Study sections (several).,

2000: Chairman NIH, Centers of Biomedical Research Excellence (COBRE) Study Section,

2000 -2005: Member and Chairman NIDDK-B, Diabetes, Endocrinology and Metabolism Study Section,

1998: Member Peer Review Panel on Endocrine Disruptors, NIEHS,

2000: Member Peer Review Panel on Endocrine Disruptors, NIEHS,

2002: Member Peer Review Panel on Endocrine Disruptors, NIEHS,

2005: Member NIH, Special Study Section on Hormones in Menopause.,

2006: Ad hoc member Four NIH study sections: Molecular Oncology 2, Endocrinology, Metabolism, Nutrition and Reproductive Sciences, Integrative Clinical Endocrinology and Reproduction, and ZRG1 EMNR-E 02M,

2007: Member, planning committee 10th international Pituitary Congress,

2007: Chairman Special NIDDK Study Section, Diabetes, Endocrinology and Metabolic Diseases,

2009: Chairman Special NIDDK Study Section, Diabetes, Endocrinology and Metabolic Diseases,

2008: Member ST-2 Study Section, the Susan G. Komen for the Cure,

2009: Chairman NIDDK, Diabetes, Endocrinology and Metabolic Diseases Study Section,

Contact Information

Academic - Vontz Center for Molecular Studies
3125 Eden Avenue
Ohio, 45267
Phone: 513-558-4821
nira.ben-jonathan@uc.edu